We’re proud that iTrace Prime is making it possible for doctors to utilize even more needed information from a single device.” “The quality and stability of the ocular surface is a critical component of understanding a patient’s vision issues as we strive to help surgeons provide exceptional outcomes after eye surgery. “We’re proud to continue developing iTrace capabilities as we stay at the leading edge of the vision industry,” said Ray Sievert, Tracey’s Executive Vice President of Sales and Marketing. A proprietary algorithm then generates a number from 0-10 - the Tear Film Index (TFI™) - which assesses the degree to which the effects of Dry Eye Disease (DED) are impacting a patient’s vision. This latest addition to iTrace will record many images of the ocular surface for 12 seconds starting immediately after a blink, which can then reveal the local shape and sharpness changes of Placido rings.
Itrace ray tracing upgrade#
The iTrace Prime upgrade also includes Tear Film Analysis, a new capability that surgeons have been waiting for. This additional data provides practitioners an even more comprehensive picture of patients’ eyesight while enhancing their ability to identify the source of vision problems, making it easier to plan the best treatment option for every patient. The “Prime Dashboard” includes two new indices: the Corneal Performance Index (CPI™) and the Quality of Vision Index (QVI™) to the proprietary Dysfunctional Lens Index (DLI™).
This new software version (7.0) adds many valuable new features that improve the range of information able to be gathered from a single device. HOUSTON-( BUSINESS WIRE)-Tracey Technologies announced the release of iTrace Prime, an upgraded software for the iTrace Ray Tracing Aberrometer and Corneal Topographer from a trusted leader in ophthalmic technology development.
0 kommentar(er)
